A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes ...
DXCM reports positive CONNECT trial results as Dexcom G7 improves HbA1c and time in range in adults with Type 2 diabetes not using insulin.
Wondering which fruit is better for blood sugar control? Know how grapes and apples affect glucose levels, nutrition, fibre ...
A large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians ...
We conducted a 48-week placebo-controlled trial (that included a 24-week dose-escalation period for uptitration of survodutide to 6.0 mg and a 24-week dose-maintenance period) in participants aged ≥18 ...
A new crossover trial suggests that daily L-tyrosine was well tolerated in healthy men, but researchers caution that safety beyond 4 weeks, at higher doses, and across more diverse groups remains ...
A large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians was safe and improved the quality of clinical decision-making, but did not ...
Exploratory endpoints included assessments of blood pressure, weight, cholesterol, and additional markers for pre-diabetes Preliminary results to be presented at Integrative Personalised Medicine ...
Bio-Gate: Update On The Hiprevision Clinical Trial For Hyprotecttm-Coated Hip Revision Implants. Study protocol published ...
Researchers tested the oral GLP-1 drug aleniglipron in a phase 2 trial. Participants on the highest dose lost ~12% body ...
The largest-ever U.K. trial of a urine test used across the NHS to spot when patients skip their medication has shown it may improve adherence to treatment. Led by researchers at the University of ...
Obsolescence of control arms at data maturation impedes comparative effectiveness and ICER estimation, potentially contributing to prolonged delays between registration and real-world availability.